Distilled from 200+ enterprise deployments. These are the principles that separate successful Claude programmes from stalled pilots.
Start with literature review and synthesis — high-value, lower-risk than regulatory submissions.
This applies across pharmaceuticals & life sciences organisations of all sizes. Teams that follow this principle consistently report better adoption rates and faster ROI realisation.
Always maintain a human scientific expert as the designated reviewer for any AI-generated regulatory content.
This applies across pharmaceuticals & life sciences organisations of all sizes. Teams that follow this principle consistently report better adoption rates and faster ROI realisation.
Use Claude's 200K context to process complete study reports and cross-reference all supporting data.
This applies across pharmaceuticals & life sciences organisations of all sizes. Teams that follow this principle consistently report better adoption rates and faster ROI realisation.
Validate AI outputs against a gold-standard reference set before deploying to live regulatory work.
This applies across pharmaceuticals & life sciences organisations of all sizes. Teams that follow this principle consistently report better adoption rates and faster ROI realisation.
Establish a formal AI validation protocol that satisfies 21 CFR Part 11 and GxP requirements.
This applies across pharmaceuticals & life sciences organisations of all sizes. Teams that follow this principle consistently report better adoption rates and faster ROI realisation.
Deploy in a GxP-compliant cloud environment with full audit trail capabilities.
This applies across pharmaceuticals & life sciences organisations of all sizes. Teams that follow this principle consistently report better adoption rates and faster ROI realisation.
Engage regulatory agency contacts proactively to understand their position on AI-generated submissions.
This applies across pharmaceuticals & life sciences organisations of all sizes. Teams that follow this principle consistently report better adoption rates and faster ROI realisation.
Build a library of approved regulatory language (terms, phrases) that Claude uses consistently.
This applies across pharmaceuticals & life sciences organisations of all sizes. Teams that follow this principle consistently report better adoption rates and faster ROI realisation.
Use Claude for internal medical review board materials — significantly reduces prep time.
This applies across pharmaceuticals & life sciences organisations of all sizes. Teams that follow this principle consistently report better adoption rates and faster ROI realisation.
Track submission cycle time reduction as your headline ROI metric for board reporting.
This applies across pharmaceuticals & life sciences organisations of all sizes. Teams that follow this principle consistently report better adoption rates and faster ROI realisation.
❌ Deploying without a clear ROI measurement framework
❌ Skipping the change management and training programme
❌ Trying to automate safety-critical decisions without human review
❌ Going straight to customer-facing AI without internal pilot first
90-minute session. No obligation. Discover your highest-impact deployment opportunities in 30 days.
3,000+ enterprise leaders read it every week. Join them.